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Abstract
Acute asthma exacerbations can be severe and life-threatening. In some cases, standard interventions and management
do not result in reversal of bronchoconstriction. It is crucial to detect patients with impending respiratory failure and
escalate management to invasive mechanical ventilatory support and, in refractory cases, interventions like extracorporeal membrane oxygenation (ECMO). This technique is not frequently utilized but has proven to be effective in
settings of resistant status asthmaticus.
We describe a Case of respiratory distress secondary to asthma exacerbation, which rapidly devolved into status
asthmaticus. It was resistant to all standard and off-label management modalities, which necessitated the use of venovenous extracorporeal CO2 removal (VVECCO2R). ECMO was utilized in our case with great success. In this article, we
aim to raise awareness of the importance of VVECCO2R in the treatment of refractory status asthmaticus and the difﬁculties that prevent widespread implementation of the technique across healthcare facilities.
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1. Introduction

A

sthma is managed with short-acting betareceptor agonists, long-acting beta-receptor
agonists, and corticosteroids as mainstay therapy.
However, acute asthma exacerbations can become
refractory to those therapies, necessitating the use of
invasive mechanical ventilation to provide the patient with adequate airﬂow. Approximately 4% of
patients hospitalized with asthma exacerbations
require this invasive intervention.1
Status asthmaticus is a severe form of asthma
exacerbation that does not respond to the usual
treatment modalities of reactive bronchoconstriction. It can last from minutes to several hours
and can be a life-threatening condition even when
properly managed. Risk factors for status asthmaticus include previous ICU admission and recent
increased use of bronchodilator treatment without
symptom improvement. In patients with severe

asthma refractory to standard medical treatment
and mechanical ventilation, extracorporeal life
support can provide a means of carbon dioxide
removal and oxygenation.
We present a Case of acute severe asthma exacerbation that failed to resolve despite the use of all
recommended and off-label lines of treatment,
requiring the utilization of extracorporeal gas
exchange.

2. Case presentation
A 17-year-old male with a past medical history of
asthma and psoriasis presented to the emergency
department (ED) with complaints of progressive
shortness of breath over the preceding 3 days. The
patient had a long history of asthma since childhood, with multiple emergency room visits. The
patient was under close follow with a pulmonologist
due to uncontrolled asthma. He was previously
educated on inhaler use and the importance of
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remaining compliant with his medication. The
family reported that he was occasionally not
compliant with the inhalers. His home medication
was adjusted multiple times and included umeclidinium/vilanterol 62.5e25 mcg/inh inhalation powder daily, cetirizine 10 mg daily, prednisone 40 mg
oral daily, and albuterol sulfate as needed. The patient reported using the rescue inhaler once daily for
the preceding three weeks. However, for two days
prior to his presentation in the ED, he admitted to
using the inhaler every 2e3 h with no improvement.
At the time of presentation to the emergency room,
he was in respiratory distress, vomiting, cyanotic,
and unable to speak in full sentences. Physical examination revealed severe bilateral biphasic
wheezes.
The patient was treated with 125 mg of methylprednisolone and 2 gm of IV magnesium sulfate,
before being intubated in the emergency department secondary to severe respiratory distress,
impending respiratory failure, and intractable
vomiting. The patient was admitted to the ICU,
ventilated under pressure regulated volume control,
PEEP of 5, FiO2 100%, tidal volume 400, respiratory
rate 20, O2 saturation 100%. Chest x-ray obtained
post-intubation revealed an endotracheal tube in
place, with no acute pulmonary ﬁndings [Fig. 1].
The ABG obtained post-intubation revealed a pH
of 7.09 (7.35e7.45), PaO2 337 mmHg (>80 mmHg),

PaCO2 91 mmHg (35e45 mmHg), HCO3 21.3 mmol/
L (22e26 mmol/L). Initial labs revealed a Hgb
15 gm/dL (12e16 gm/dL), WBC 24.7 (4.8e10.8), with
absolute neutrophil count of 9.3 (1.4e6.5), eosinophils 1.4 (0.0e0.7), and lymphocytes 1.4 (1.2e3.4).
The patient's peak airway pressure was
increasing, reaching as high as 50 mmHg, so his
ventilation was switched to pressure-control to
prevent pulmonary barotrauma. At that time the
patient was sedated and was started on a vecuronium infusion. Albuterol-Ipratropium-Inhalation
dose was increased to 3 mL every 2 h via nebulizer
before the initiation of the vecuronium. The patient
was also treated with epinephrine 0.5 mg intramuscular and terbutaline 0.25 mg subcutaneous for
3 times in an effort to decrease his airway
resistance.
A second ABG revealed worsening of the condition, with a pH of 6.91, PaO2 124, PaCO2 146, and
HCO3 19.2. The patient was given bicarbonate
pushes and started on a bicarbonate infusion for
severe acidosis. A repeat ABG 2 h later showed no
signiﬁcant improvement, with a pH of 6.97, PaCO2
141 and HCO3 of 22. We then added theophylline to
the therapy, which failed to improve the patient's
airway resistance. The ABG 1.5 h after the initiation
of theophylline, showed worsening of the hypercapnia, with a pH of 6.94, PaCO2 156 and incalculable HCO3.

Fig. 1. Chest x-ray demonstrating hyperinﬂated lungs despite intubation.

With pressure-control ventilation, the tidal volume dropped to around 150 ml, and minute ventilation dropped to 3000 ml/min. The following ABG
2 h later, revealed a pH 6.93, PaO2 210, PaCO2 199,
and incalculable HCO3, while O2 saturation
remained at 100%. The patient was given a ketamine
push, 0.5 mg/kg, followed by a ketamine infusion,
0.5 mg/kg/hr, which also failed to decrease airway
resistance. PaCO2 remained at 198 after 1 h.
A follow-up chest x-ray showed signs suggestive
of a pneumomediastinum, which was expected
given the patient's exceedingly high airway pressures [Fig. 2].
An electrocardiogram was obtained, which
demonstrated low voltage readings, agreeable with
the state of lung hyperinﬂation [Fig. 3].
The patient was too unstable to transfer to the
operating room to be put under general anesthesia
with inhaled sevoﬂurane. At that time, the patient
was only eligible for veno-venous extracorporeal
carbon dioxide removal (VVECCO2R).
Our facility is not readily equipped to deploy
VVECCO2R, so several communications were made
in an attempt to transfer the patient to another facility where the technique is more standardized. He
was accepted to a facility but was too unstable to
transport. A specialized team from the accepting
facility came to our facility's Intensive Care Unit and
prepared the patient for extracorporeal gas
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exchange. The patient was started on VVECCO2R at
the bedside. An ABG obtained 30 min later revealed
an improved pH of 7.12, PaO2 125, PaCO2 120.
Another ABG at 60 min after VVECCO2R revealed a
pH of 7.25, PaO2 120, PaCO2 89. Total duration of
hospitalization in our facility was 20 h before we
transferred the patient to a hospital that is better
equipped to manage a patient on VVECCO2R.
He remained on VVECCO2R for 21 days. He was
then transitioned back to mechanical ventilation for
another 30 days. The patient was successfully
weaned off invasive ventilation and discharged from
the hospital to respiratory rehabilitation. A followup chest x-ray demonstrated atelectasis and
possible consolidation after prolonged invasive
mechanical ventilation [Fig. 4].

3. Discussion
Traditionally, asthma exacerbations that are
resistant to pharmacological interventions are
managed with non-invasive and invasive ventilator
support. Optimizing ventilator settings to maximize
CO2 removal and decrease hyperinﬂation can be
challenging as several complications can occur.
These include sepsis, ARDS, elevated intrathoracic
pressure, right ventricular strain causing inadequate
preload, and positive pressure ventilation leading to
tension pneumothorax.2 Additionally, airway stenosis and subsequent air trapping in severe asthma

Fig. 2. Chest x-ray demonstrating worsening of pulmonary inﬂation despite mechanical ventilation and treatment to bronchoconstriction, with
possible pneumomediastinum.
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Fig. 3. A low voltage EKG obtained during management, demonstrating a hyperinﬂated chest.

can limit the effectiveness of mechanical ventilation
altogether. In these scenarios, extracorporeal membrane oxygenation (ECMO) may be utilized to provide gas exchange and adequate carbon dioxide
removal with minimal to no reliance on a
ventilator.3
ECMO is a method of providing tissue oxygenation and perfusion in settings of inadequate respiratory or cardiovascular function. Veno-arterial
ECMO (VA-ECMO) bypasses both the heart and

lungs and is used in settings where simultaneous
hemodynamic and respiratory support is needed.
Veno-venous ECMO (VV-ECMO) is used in settings
of preserved cardiac function as it offers only respiratory support. VV-ECMO has historically been
used to manage acute respiratory distress syndrome
(ARDS), but since 1992, it has gained popularity as a
treatment for severe asthma exacerbations, perhaps
because of its favorable complication proﬁle.4 Even
so, hemorrhagic, renal, and cardiovascular

Fig. 4. A chest x-ray obtained after the patient's recovery, demonstrating atelectasis and possible consolidation after prolonged invasive mechanical
ventilation.

complications have been noted with its use.5 Current indications for ECMO include hypoxemic respiratory failure with PaO2/FiO2 <100 mmHg despite
optimized ventilator settings, and hypercapnic respiratory failure with an arterial pH < 7.20.6,7
In the literature, a survival rate of 83.5% has been
reported for patients with severe asthma exacerbations undergoing VV-ECMO. Compared to survivors, non-survivors had signiﬁcant differences in
age, pH, PEEP, ECMO duration, and complication
rate. Importantly, respiration rate, fraction of
inspired oxygen, peak inspiratory pressure and
mean airway pressure signiﬁcantly improved in
patients who underwent ECMO after mechanical
ventilation failed.5 Unfortunately, ECMO is not
widely used to treat status asthmaticus because of
multiple obstacles that include lack of equipment at
healthcare facilities, ill-equipped staff, and transportation limitations. Given the beneﬁts and favorable complication proﬁle, ECMO should be more
accessible and widely used to manage status asthmaticus refractory to ventilator support.

4. Conclusions
ECMO remains a lifesaving option in cases of
status asthmaticus with severe hypercapnic respiratory failure unresponsive to medical treatments
and mechanical ventilatory support. Increasing
physician awareness of ECMO indications, equipping hospitals with proper equipment, and training
healthcare staff could make this modality more
ubiquitous and improve patient outcomes.
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